IVI and WHO
World Health Organization (WHO):
Party of the IVI Establishment Agreement
On 12 May 1997, the Fiftieth World Health Assembly (WHA50) voted to approve the Establishment of the IVI, becoming a founding member of the Institute.
WHO Leadership at IVI
The WHO has a two permanent seats on the IVI Board of Trustees (BOT) and is normally represented by the Regional Office for the Western Pacific (WPRO). Dr. Takseshi Kasai, Regional Director of WPRO, is the current WHO representative on the IVI BOT.
IVI: Partner on WHO Committees and Initiatives
IVI scientists and researchers play key roles across the WHO ecosystem, codeveloping solutions on vaccine delivery, treatment costs, and vaccine safety. The development of IVI’s Oral Cholera Vaccine enabled the WHO to establish the ICG-administered cholera vaccine stockpile and the Ending Cholera—A Global Roadmap to 2030 strategy. IVI is currently a member of the following WHO committees and initiatives: